Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Roadmap: Finalized Plan For Implementing New Regs Coming Next Month?

Executive Summary

A crucial document for industry, the roadmap to the implementation of the EU's new medtech rules, finally seems on the cusp of readiness – four months after the rules entered into force.

You may also be interested in...



Notified Bodies Apply For EU MDR/IVDR Designations Despite Document Shortfall

If there is a delay in appointing EU notified bodies under the new Medical Device and IVD Regulations, it will impact the whole sector's ability to comply in time. But nothing is quite ready.

Q&A: With New EU Regs Taking Effect, What Can Industry Do To Be Proactive?

The new EU Medical Device and IVD Regulations will be published any day and take effect within weeks. In this interview, John Brennan, outgoing regulations chief for Medtech Europe, tells Medtech Insight what the European Commission, competent authorities and industry should do now to avoid obstacles.

European Commission Publishes Draft Rules In Bid To Reclassify Non-Medical Active Products

The European Commission has launched an initiative to ensure products without a medical purpose that fall under the Medical Device Regulation are appropriately classified by risk, and subject to the same pre- and post-market requirements as comparable medical devices.

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT121531

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel